Skip to content

Sanomedics, Inc.: 10-Q filed 2013-11-21

What Sanomedics, Inc. reported in its quarterly report filed 2013-11-21 (fiscal Q3 2013): 28 published measures, 73 facts as tagged in accession 0001477932-13-005823.

This filing

Form
10-Q (quarterly report)
Filed
2013-11-21
Fiscal period
fiscal Q3 2013
Accession
0001477932-13-005823 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Sanomedics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-304,488,944USD
At 2012-12-3190,217USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-09-308,188,621USD
At 2012-12-313,254,403USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-30-3,699,677USD
At 2012-12-31-3,164,186USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-3093,314USD
At 2012-12-3126,084USD
At 2012-09-309,080USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-76,787USD92
2013-01-01 to 2013-09-30-2,646,765USD273
2012-07-01 to 2012-09-30-864,583USD92
2012-01-01 to 2012-09-30-1,901,404USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-09-30162,302USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-562,302USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-09-30-11,560,047USD
At 2012-12-31-8,913,282USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-3095,426USD
At 2012-12-3117,049USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-07-01 to 2013-09-3093,000USD92
2013-01-01 to 2013-09-30348,738USD273
2012-07-01 to 2012-09-30204,888USD92
2012-01-01 to 2012-09-30369,751USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-462,743USD92
2013-01-01 to 2013-09-30-1,142,098USD273
2012-07-01 to 2012-09-30-829,126USD92
2012-01-01 to 2012-09-30-1,756,991USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-301,257,877USD
At 2012-12-3136,372USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-07-01 to 2013-09-308,344USD92
2013-01-01 to 2013-09-3061,459USD273
2012-07-01 to 2012-09-3035,457USD92
2012-01-01 to 2012-09-30144,413USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-305,334,182USD
At 2012-12-313,241,903USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2013-09-302,891,635USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-30866,453USD
At 2012-12-318,117USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-07-01 to 2013-09-30586,459USD92
2013-01-01 to 2013-09-301,353,302USD273
2012-07-01 to 2012-09-30823,930USD92
2012-01-01 to 2012-09-301,752,131USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-09-30290,625USD
At 2012-12-312,171USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30123,716USD92
2013-01-01 to 2013-09-30211,204USD273
2012-07-01 to 2012-09-30-5,196USD92
2012-01-01 to 2012-09-30-4,860USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-07-01 to 2013-09-3024,250USD92
2013-01-01 to 2013-09-3077,750USD273
2012-01-01 to 2012-09-308,500USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-3027,326,723shares
At 2012-12-3120,403,586shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-307,853,042USD
At 2012-12-315,748,691USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-76,787USD92
2013-01-01 to 2013-09-30-2,646,765USD273
2012-07-01 to 2012-09-30-864,583USD92
2012-01-01 to 2012-09-30-1,901,404USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30466,498USD92
2013-01-01 to 2013-09-30920,305USD273
2012-07-01 to 2012-09-30617,969USD92
2012-01-01 to 2012-09-301,370,685USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-09-306,509USD273
2012-01-01 to 2012-09-303,195USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-07-01 to 2013-09-30385,955USD92
2013-01-01 to 2013-09-30-1,504,667USD273
2012-07-01 to 2012-09-30-35,457USD92
2012-01-01 to 2012-09-30-144,413USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-86,226USD273
2012-01-01 to 2012-09-30345USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-130,500USD273
2012-01-01 to 2012-09-3034,442USD274

Inspect the source

Entity
Sanomedics, Inc. / CIK 0001501972
Captured
SEC response SHA-256
6c0af9720a10416680c6fc5e8d6f44722f1dfb1953be5b58d23cea65d053ff75

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001501972.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))